Yescarta Interactions
There are 302 drugs known to interact with Yescarta (axicabtagene ciloleucel), along with 5 disease interactions. Of the total drug interactions, 68 are major, 210 are moderate, and 24 are minor.
- View all 302 medications that may interact with Yescarta
- View Yescarta disease interactions (5)
Most frequently checked interactions
View interaction reports for Yescarta (axicabtagene ciloleucel) and the medicines listed below.
- Actemra (tocilizumab)
- Amicar (aminocaproic acid)
- Austedo (deutetrabenazine)
- Blincyto (blinatumomab)
- Buphenyl (sodium phenylbutyrate)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Diacomit (stiripentol)
- Esbriet (pirfenidone)
- Feiba (anti-inhibitor coagulant complex)
- Fosrenol (lanthanum carbonate)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Inderal (propranolol)
- Isentress (raltegravir)
- isoniazid
- Jadenu Sprinkle (deferasirox)
- Jynarque (tolvaptan)
- Keflex (cephalexin)
- Kymriah (tisagenlecleucel)
- Kynamro (mipomersen)
- Luxturna (voretigene neparvovec ophthalmic)
- methotrexate
- Neulasta (pegfilgrastim)
- Ofev (nintedanib)
- Onpattro (patisiran)
- Procysbi (cysteamine)
- Prograf (tacrolimus)
- Rapamune (sirolimus)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
Yescarta disease interactions
There are 5 disease interactions with Yescarta (axicabtagene ciloleucel) which include:
Report options
More about Yescarta (axicabtagene ciloleucel)
- Yescarta consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
Columvi
Columvi is used to treat certain types of diffuse large B-cell lymphoma (DLBCL) or large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.